Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Truness of Full Arch Impressions in All on x Cases

NCT07550725 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-05-01
Last updated
2026-09-10

Condition(s) studied

Truness of Impression Techniques in All on x CasesTrueness of Full Arch Implant Prosthesis Impression

Investigational drug(s) / intervention(s)

photogrammetry based full arch impressionDigital Impression Using Splinted Scan BodiesConventional Open-Tray Implant Impression

photogrammetry based full arch impression: use of photogrammetry system to capture the positions of All on X implants digitally without physical impression material. This technique aims to achieve precise measurements and increase patient satisfaction

Digital Impression Using Splinted Scan Bodies: Digital full-arch impression using splinted scan bodies connected with resin to enhance stability. An intraoral scanner captures the splinted assembly for framework fabrication. Accuracy and patient satisfaction will be evaluated.

Conventional Open-Tray Implant Impression: Traditional full-arch open-tray impression using polyether or VPS material with splinted impression copings. This serves as the standard comparator for evaluating accuracy and patient satisfaction.

Study summary

This study aims to compare the trueness and precision of three impression methodologies photogrammetry, digital intraoral scanning with splinted scan bodies, and conventional open tray impressions in the context of the All-on-X treatment concept. This will provide valuable evidence for clinicians considering digital workflows for implant-supported prostheses. Does the use of photogrammetry and digital impression techniques with splinted scan bodies result in improved accuracy in implant position transfer in the All-on-X concept compared to conventional open tray impressions?

Eligibility

Sex
MALE
Min age
55 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 45-65 years. * Fully edentulous or partially edentulous maxilla requiring full-arch rehabilitation. * Sufficient maxillary bone volume to support at least four implants according to the All-on-X protocol. * Systemically healthy patients with no contraindications to dental implant surgery (ASA I-II classification). * Demonstrated ability to maintain adequate oral hygiene * Willingness to participate in the study and comply with follow-up visits and required maintenance protocols. * Patients seeking a fixed, implant-supported prosthesis for the maxilla due to missing teeth and inability to use removable prostheses effectively. * Acceptable radiographic findings with no signs of pathology, infection, or significant anatomical limitations. Exclusion Criteria: * Uncontrolled systemic diseases (e.g., uncontrolled diabetes, osteoporosis, immunosuppressive disorders) * History of radiation therapy to the head and neck region * Active periodontal disease or untreated caries * Maxillary cysts, tumors, or pathologies * Poor oral hygiene or inability to maintain postoperative care * Insufficient bone volume for All-on-X without extensive grafting * Maxillary sinus pathology or oroantral fistula * Psychiatric illness or cognitive impairment affecting compliance * Bruxism or parafunctional habits * Pregnant or lactating women * History of implant failure or titanium allergy * Use of bisphosphonates or antiresorptive medications * Heavy smoking (\>10 cigarettes/day) * Inability or unwillingness to attend follow-up visits * Diagnosed or symptomatic temporomandibular joint disorders (pain, clicking, locking, limited opening)

Primary outcome measure(s)

  • Accuracy measured using 3D inspection software (Geomagic Control X). — Immediately after measurements taking

Trial sites (1)

FacilityCityRegionStatus
October 6 University Giza Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07550725 on ClinicalTrials.gov ↗ ← All trials in Egypt